Jonathan Schwartz, MD
Psychiatry · Mashpee, MANPI 1053393462
Payments from drug & device makers
What this record shows
This record is dominated by other: $85,875 of the $92,893 with a category attached, or 92.4%. Neuronetics, Inc. accounts for 94.7% of it on its own, with 18 other manufacturers making up the rest. Reporting peaked in 2024 at $87,236 and has fallen 98.7% since, to $1,107 in 2025. Among psychiatry clinicians in MA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 257 payments — averaging $361.45 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuronetics, Inc.$88K
- AbbVie$858
- Otsuka America Pharmaceutical, Inc.$758
- Axsome Therapeutics, Inc.$554
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$527
- Sunovion Pharmaceuticals Inc.$504
- plus $2K from 13 others
What the payments were for
- Food & beverage$6,9587%
- Education$600%
- Other$85,87592%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuronetics, Inc. | 33 | $88,012 |
| AbbVie(2 entities) | 42 | $858 |
| Otsuka America Pharmaceutical, Inc. | 25 | $758 |
| Axsome Therapeutics, Inc. | 15 | $554 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 24 | $527 |
| Sunovion Pharmaceuticals Inc. | 25 | $504 |
| Lundbeck LLC | 27 | $405 |
| Johnson & Johnson | 14 | $252 |
| Corium, LLC | 10 | $162 |
| Supernus Pharmaceuticals, Inc. | 6 | $157 |
| Alkermes, Inc. | 7 | $149 |
| Vanda Pharmaceuticals Inc. | 8 | $126 |
| Indivior Inc. | 4 | $126 |
| Shire North American Group Inc | 5 | $92 |
| Ironshore Pharmaceuticals Inc. | 5 | $86 |
| E.r. Squibb & Sons, L.L.C. | 2 | $46 |
| Teva Pharmaceuticals USA, Inc. | 3 | $43 |
| Avion Pharmaceuticals | 1 | $22 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- NEUROSTAR TMS THERAPY SYSTEM$86,654
- REXULTI$250
- Auvelity$250
How this compares
$92,893 in reported general payments places this provider in the 95th percentile of 1,431 psychiatry providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Austedo XrDeutetrabenazine | 19 | $126,106 |
| RexultiBrexpiprazole | 24 | $34,266 |
| Lurasidone Hcl | 11 | $11,692 |
| Buspirone Hcl | 37 | $2,403 |
| Aripiprazole | 13 | $2,010 |
| Duloxetine Hcl | 25 | $1,663 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 38 | $1,231 |
| Methylphenidate Hcl | 32 | $1,154 |
| Zolpidem Tartrate ErZolpidem Tartrate | 17 | $1,035 |
| Prazosin Hcl | 20 | $961 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 60 | $716 |
| Trazodone Hcl | 36 | $651 |
| Lamotrigine | 27 | $620 |
| Bupropion XlBupropion Hcl | 27 | $579 |
| Fluoxetine Hcl | 44 | $497 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Teva Pharmaceuticals USA, Inc.Austedo Xr | $43 | $126,10619 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $758 | $34,26624 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,431 psychiatry providers in Massachusetts.
Other psychiatry in Mashpee
- Theresa CerulliNorth Andover$724K
- Andrew AldridgeMedford$407K
- Amjad BahnassiWorcester$352K
- Ximena Sanchez-SamperBoston$258K
- Robert AlexanderBelmont$170K
- George PapakostasBoston$170K
- Xiangyang LiMilford$166K
- Ernesto ZilberbergNorth Andover$141K
- Maurizio FavaBoston$120K
- Craig SurmanCambridge$111K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.